A Study of Daratumumab

Clinical trial NCT05438043 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05438043
Sponsor: Janssen Research & Development, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2022-12-15
Primary completion: 2029-01-31
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.